Dr. Keith D. Forwith, MD
ENT (Otolaryngology) (Otolaryngology Physician)
- Medicare participating
At a glance
- Medical school
- University of Cincinnati College of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 614
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: University of Cincinnati College of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Otolaryngology Physician primary
KY license 36650 · IN license 01054405A -
Specialist
KY license 36650
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Norton Hospitals, Inc Louisville, KY
- Baptist Health Louisville Louisville, KY
- Baptist Health Floyd New Albany, IN
- University of Louisville Hospital Louisville, KY
- Norton Clark Hospital Jeffersonville, IN
Medical groups
- Advanced Ent and Allergy PLLC (38 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 614
- Services billed
- 3,511
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Professional service for multiple injections of allergen | 909 | 132 |
| Test for allergy using allergenic extract | 440 | 11 |
| Test for allergy using allergenic extract injected into skin | 381 | 11 |
| Established patient office or other outpatient visit, 30-39 minutes | 225 | 151 |
| Established patient office or other outpatient visit, 20-29 minutes | 145 | 116 |
| Professional service for single injection of allergen | 129 | 36 |
| New patient office or other outpatient visit, 45-59 minutes | 114 | 114 |
| Ultrasound scan of head and neck soft tissue | 88 | 78 |
| Established patient office or other outpatient visit, 10-19 minutes | 77 | 67 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Louisville, KY | 106 |
| Fluticasone Propionate Other prescribers in Louisville, KY | 97 |
| Azelastine Hcl Other prescribers in Louisville, KY | 86 |
| Omeprazole Other prescribers in Louisville, KY | 53 |
| Synthroid (levothyroxine sodium) Other prescribers in Louisville, KY | 51 |
| Ofloxacin Other prescribers in Louisville, KY | 37 |
| Mupirocin Other prescribers in Louisville, KY | 37 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Louisville, KY | 32 |
| Montelukast Sodium Other prescribers in Louisville, KY | 30 |
| Ondansetron Hcl Other prescribers in Louisville, KY | 26 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 17 payments worth $580 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $199 |
|---|---|
| Genzyme Corporation | $162 |
| Inspire Medical Systems, Inc. | $149 |
| Ethicon US, LLC | $28.27 |
| Smith+nephew, Inc. | $23.47 |
| GlaxoSmithKline, LLC. | $17.45 |
| Food and Beverage | $580 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $38,410 in research payments for these studies, mostly to the institutions running them.
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
Sanofi US Services Inc. · Active, not recruiting · NCT06834360 - EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
Genzyme Corporation · Completed · NCT04998604
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.